Stay updated on OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.

Latest updates to the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4. This appears to be an internal metadata revision rather than any changes to the study details or public content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site maintenance or release update without altering the study record content.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded the disease term 'Squamous cell carcinoma of the head and neck' and introduced a Genetic and Rare Diseases Information Center resources section on the study page.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision tag updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.